Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2020-06-02 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
02-06-20-EN.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled 'Acquisitions and disposals of own shares' and details the repurchase (acquisition) and disposal of UCB shares by the company itself during a specific period (May 22, 2020, up to June 1, 2020). This activity directly relates to the company's share repurchase program and transactions in its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal disclosure, not just an announcement of a report, and it details the transactions themselves.
2020-06-02 English
02-06-20-FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Rachat et Aliénation d'actions propres" (Repurchase and Disposal of Own Shares) and details transactions where UCB SA bought back its own shares on Euronext Bruxelles and disposed of shares related to employee stock option plans between May 22, 2020, and June 2, 2020. This activity directly corresponds to the definition of a company reporting transactions involving its own shares. Reviewing the filing types: - 10-K/IR/ER/MRQ are financial reports. - DEF 14A is remuneration. - DIRS is director's dealing (insider trades), not general company share transactions. - The most specific category for reporting the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). Therefore, the classification is POS.
2020-06-02 French
02-06-20-NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2020) and disposed of shares related to employee stock option plans between May 22, 2020, and June 2, 2020. This activity directly corresponds to the definition of a company reporting on buying back or selling its own shares. This matches the definition for Transaction in Own Shares (Code: POS). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a very specific corporate action.
2020-06-02 Dutch
20200522 UCB Acquisitions and disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details 'Acquisitions of own shares' and 'Disposals of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2020, including specific dates, quantities, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a direct disclosure of the transaction, not an announcement of a report.
2020-05-22 English
20200522 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Rachat et Aliénation d'actions propres" (Share Repurchase and Disposal) and details transactions where UCB SA bought back its own shares (Rachat d'actions propres) and disposed of shares related to employee incentive plans (Aliénation d'actions propres). This activity directly relates to changes in the company's outstanding share count and capital structure management, specifically share repurchases/treasury stock transactions. This aligns precisely with the definition for 'Transaction in Own Shares' (POS). Although it involves capital management, it is more specific than 'Capital/Financing Update' (CAP) as it focuses solely on treasury stock movements.
2020-05-22 French
20200522 Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details specific transactions where UCB NV bought back its own shares on Euronext Brussels between May 13 and May 22, 2020, and also disposed of shares related to employee incentive plans. This activity directly relates to the company managing its own stock holdings, which falls under the definition of 'Transaction in Own Shares' (POS). It is not a full annual report (10-K), an earnings release (ER), or a general management discussion (MDA).
2020-05-22 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.